Page 377 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 377

CHAPTER 20  Drugs Used in Asthma     363



                     Subclass,     Mechanism of                                                 Pharmacokinetics,
                     Drug          Action         Effects                 Clinical Applications  Toxicities
                     ANTI-INTERLEUKIN-5 PATHWAY ANTIBODIES AND OTHER ANTIBODIES
                       •  Mepolizumab  Humanized anti-IL-5   Reduces frequency of asthma   Severe asthma inadequately   Parenteral • duration 2–4 wk • Toxicity:
                                   antibody; reduces   exacerbations      controlled by above agents,   Injection site reactions (anaphylaxis
                                   circulating and                        with associated eosinophilia  extremely rare)
                                   tissue eosinophils

                       •  Dupilumab  Humanized    Reduces frequency of asthma   Severe asthma inadequately   Parenteral injection every 2–4 wk
                                   antibody against   exacerbations; improves pulmonary   controlled by ICS/LABA therapy
                                   IL-4α receptor for   function
                                   IL-4 and IL-13
                     Reslizumab and benralizumab: Similar to mepolizumab






                    PREP AR A TIONS A V AIL ABLE


                          GENERIC NAME             AVAILABLE AS                 GENERIC NAME             AVAILABLE AS
                        SHORT-ACTING BETA-AGONIST BRONCHODILATORS         Budesonide             Pulmicort
                     Albuterol               Generic, Proventil, ProAir, Ventolin  Ciclesonide   Alvesco
                     Bitolterol              Tornalate                    Mometasone             Asmanex
                     Ephedrine               Generic                      Flunisolide            AeroBid, Aerospan
                     Epinephrine             Generic, Adrenaline          Fluticasone            Flovent
                                                                          Triamcinolone          Azmacort
                     Levalbuterol            Xenopex
                                                                                        COMBINATION INHALERS
                     Metaproterenol          Generic, Alupent
                                                                          Formoterol/budesonide  Symbicort
                     Pirbuterol              Maxair
                                                                          Formoterol/mometasone  Dulera
                     Terbutaline             Breathaire, Brethine         Salmeterol/fluticasone  Advair
                        SHORT-ACTING ANTIMUSCARINIC BRONCHODILATOR        Vilanterol/fluticasone  Breo
                     Ipratropium             Generic, Atrovent            Vilanterol/umeclidinium  Anoro
                         COMBINATION SHORT-ACTING BRONCHODILATOR                       LEUKOTRIENE INHIBITORS
                     Albuterol/ipratropium   Combivent                    Montelukast            Generic, Singulair
                       LONG-ACTING BETA-ADRENERGIC BRONCHODILATORS        Zafirlukast            Accolate
                     Formoterol              Foradil                      Zileuton               Zyflo
                     Indacaterol             Arcapta                        PHOSPHODIESTERASE INHIBITORS, METHYLXANTHINES
                     Olodaterol              Striverdi                    Dyphylline             Dilor, Dylix, Lufyllin
                     Salmeterol              Serevent                     Roflumilast            Daliresp
                        LONG-ACTING ANTIMUSCARINIC BRONCHODILATORS        Theophylline           Generic, Elixophyllin, Slo-Phyllin,
                     Aclidinium              Tudorza                                             Uniphyl, Theo-Dur, Theo-24
                     Tiotropium              Spiriva                                   MONOCLONAL ANTIBODIES
                     Umeclidinium            Incruse                      Omalizumab             Xolair
                                                                          Benralizumab           (To be determined)
                                 AEROSOL CORTICOSTEROIDS
                                             See also Chapter 39          Mepolizumab            Nucala
                     Beclomethasone          QVAR, Beclovent, Vanceril    Reslizumab             Cinqair
   372   373   374   375   376   377   378   379   380   381   382